Patient satisfaction with psoriasis therapies: an update and introduction to biologic therapy.
about
A patient-centred approach to biological treatment decision making for psoriasis: an expert consensusUltraviolet Phototherapy Management of Moderate-to-Severe Plaque Psoriasis: An Evidence-Based Analysis.XP-828L (Dermylex), a new whey protein extract with potential benefit for mild to moderate psoriasis.Patient Preferences for Treatment of Psoriasis with Biologicals: A Discrete Choice Experiment.Patient-reported treatment satisfaction and choice of dosing frequency with biologic treatment for moderate to severe plaque psoriasis.Potential role of ixekizumab in the treatment of moderate-to-severe plaque psoriasisHow psoriasis patients perceive, obtain, and use biologic agents: Survey from an academic medical center.Burden of skin diseases.Experience and challenges for biologic use in the treatment of moderate-to-severe psoriasis in Africa and the Middle East region.Durable dermatology life quality index improvements in patients on biologics associated with psoriasis areas and severity index: a longitudinal study.Patient preferences for psoriasis treatments: impact of treatment experience.Psoriasis in patients older than 65 years. A comparative study with younger adult psoriatic patients.Economic burden of moderate to severe plaque psoriasis in Canada.
P2860
Q28082166-68A7BD2C-394F-4032-B77D-FB897AC20D51Q34449302-A581EAB6-EE03-49D5-AA4E-DC78D5A63DCFQ34585886-3F2C4D34-2E19-4599-B63A-CD96FB61696EQ35658540-BA6DE0F3-FA7F-410F-ACD4-9F47F498AF67Q35766545-4B72A0BF-B0C7-4CD8-95FE-F87090152FA8Q36694323-BFE06F69-C3BD-4824-95AD-005C02457A63Q36921945-3B852E96-448C-4F13-95F9-6434F65625ACQ37519631-266045D4-2788-4344-A517-2D2A3600C84BQ38838470-3AE6CA1B-39A7-4108-8868-5F321B398C41Q40902492-9E28CB32-6678-4753-BCB6-95C57DCAB61EQ44849386-E8C9BEEA-ECA2-44BE-9E43-192DF2D69ADAQ47669886-14342127-7468-4A76-A385-C0FD8771D724Q48351106-C7BBD8F1-7BB4-4D23-A36E-23DC61CACEDC
P2860
Patient satisfaction with psoriasis therapies: an update and introduction to biologic therapy.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Patient satisfaction with psor ...... roduction to biologic therapy.
@ast
Patient satisfaction with psor ...... roduction to biologic therapy.
@en
type
label
Patient satisfaction with psor ...... roduction to biologic therapy.
@ast
Patient satisfaction with psor ...... roduction to biologic therapy.
@en
prefLabel
Patient satisfaction with psor ...... roduction to biologic therapy.
@ast
Patient satisfaction with psor ...... roduction to biologic therapy.
@en
P1476
Patient satisfaction with psor ...... roduction to biologic therapy.
@en
P2093
Andrew Y Finlay
Jean-Paul Ortonne
P2860
P2888
P304
P356
10.1007/S10227-005-0030-6
P577
2004-09-01T00:00:00Z